Inactive Instrument

Zynex Inc. Stock price OTC Bulletin Board

Equities

Advanced Medical Equipment & Technology

Sales 2024 * 227M Sales 2025 * 290M Capitalization 398M
Net income 2024 * 17M Net income 2025 * 32M EV / Sales 2024 * 1.6 x
Net cash position 2024 * 33.11M Net cash position 2025 * 11.06M EV / Sales 2025 * 1.33 x
P/E ratio 2024 *
25.6 x
P/E ratio 2025 *
13.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 39.01%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 65 95-12-31
Director of Finance/CFO 51 17-06-04
Chief Operating Officer 38 18-01-31
Members of the board TitleAgeSince
Director/Board Member 74 18-01-09
Chief Executive Officer 65 95-12-31
Director/Board Member 66 18-01-09
More insiders
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
Related indices
More about the company
  1. Stock
  2. Equities
  3. Stock Zynex, Inc.
  4. Stock Zynex Inc. - OTC Bulletin Board